China's Healthcare Market to See Surge of Investment and Opportunities in Next 15 Years
As China rolls out “Healthy China 2030” initiative and gets committed to deepening the supply-side structural reforms in 2017, Healthcare China 2017, a healthcare investment conference in China, will gather business insiders to help industry players succeed in the fast-growing healthcare market.
Last October, the Chinese government approved a blueprint called “Healthy China 2030”, pledging to build a healthy China in the next 15 years. By 2030, the size of the healthcare market is expected to reach $2.3 trillion with great investment prospects. This initiative is also in line with China’s determination to deepen the supply-side structural reforms in 2017 by substantially driving down overcapacity, and increasing efficient supply which call for stricter standards in healthcare industry. The next 15 years will see a surge of investment and changes in the industry.
Healthcare China 2017, organized by Reed Sinopharm Exhibitions (RSE), is a platform for global investors to discover more about the dynamics of healthcare business in China. To be held on May 13-14, 2017, at the Pullman Shanghai, the event will attract corporate leaders, government regulators, influencers, researchers and entrepreneurs, focusing on three main areas of investors’ interest—biomedical, medical devices, and medical services.
China’s healthcare market is projected to grow at an unprecedented CAGR of about 12 percent to reach $1 trillion by 2020, up from $357 billion in 2011, as estimated in a recent report from McKinsey & Co. Against the backdrop of key technological changes such as artificial intelligence, Healthcare China 2017 will invite the principal of IBM Watson to deliver a speech on “The Future of Artificial Intelligence in Medical Industry”. Besides, industrial experts will discuss market trends and analyse government programs aiming to promote a tiered healthcare system, ensure effective drug delivery and management.
PROMOTING INTERNATIONAL PARTNERSHIP
China’s healthcare sector has been attracting increasing investment from global investors who are keen on entering or expanding their presence in China. Healthcare China 2017, features the Top 60 innovative healthcare companies in China today, and profiles at least 500 influential CEOs and partners of leading investment companies, will be a place for global healthcare companies to demonstrate their product and process excellence, and learn China’s regulations and policies in the industry.
To register and know more about the event, visit http://www.thishealthsummit.com